Urzula Ponderrayen, Chairman of the European Union (EU). /Photo = AP
–
Bloomberg reported on the 11th that it has approved all 27 export cases so far in relation to the vaccine export approval system for the novel coronavirus infection (Corona 19) recently introduced by the European Union.
According to Bloomberg, the European Commission, a member of the EU administration, said last week that it approved four vaccine shipments to Canada, Japan and the United Kingdom, followed by an additional 23 vaccine exports.
The recent approvals included exports of vaccines to Australia, China, Mexico, New Zealand, Oman and Saudi Arabia.
Earlier, from the 30th of last month, the EU introduced a system that requires pharmaceutical companies to obtain approval from member states when exporting the Corona 19 vaccine produced in the EU outside the region. This is a result of growing concerns about the lack of supply of the COVID-19 vaccine and the slow vaccination rate.
Accordingly, pharmaceutical companies must notify member countries of new export plans in advance, and provide information on export targets and quantities. If the established criteria are not met, member states may block exports.
“We have no intention of restricting companies that respect contracts with the EU. Europe is always ready to help.” “He said.
–
In connection with the recently introduced new coronavirus infection (Corona 19) vaccine export approval system by the European Union (EU), it has approved 27 exports so far. Photos are not related to the article. /Photo = Getty Image Bank
–
The EU Commission has so far signed supply contracts with pharmaceutical companies in each country on behalf of 27 member states with a population of 450 million to secure 2.3 billion doses of a COVID-19 vaccine that has already been approved or is being developed.
Among them, the EU approved the use of three vaccines developed by Pfizer-German Bioentech, US Modena, and multinational pharmaceutical company AstraZeneca-Oxford University in the UK.
Meanwhile, the World Health Organization (WHO) has expressed concern about the EU’s scheme, saying, “It is not helpful in the current situation to not allow the free flow of ingredients necessary to make vaccines or other pharmaceuticals.”
Bobae Lee, guest reporter at Hankyung.com [email protected]
–
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
–
